Central diabetes insipidus is a rare condition that can cause extreme thirst and a frequent need to pee. It occurs when there isn’t enough antidiuretic hormone (ADH) in your body. Diabetes insipidus ...

Transient diabetes insipidus almost always begins within 24-48 h of surgery, and usually abates within several days. Both transient diabetes insipidus and the first phase of the triphasic pattern are ...

Diabetes insipidus is a rare condition that leads to excessive urination. This can lead to severe dehydration and high sodium levels — and these can mean serious complications. Share on Pinterest ...

Liquid alternative to desmopressin tablets allows for more precise dosing ...

The FDA has approved an oral liquid therapy for the treatment of central diabetes insipidus in people of all ages, according to a press release. Desmopressin acetate (Desmoda, Eton Pharmaceuticals) is ...

The study covered in this summary was published on Research Square as a preprint and has not yet been peer reviewed. The researchers suggest using as a cutoff a copeptin level of >3.4 pmol/L at ...

Mechanistically, thirst starts with the excitation of osmoregulatory cells in a brain structure called the lamina terminalis, which is located in the anterior wall of the third ventricle. The lamina ...

Diabetes mellitus—known to many as type 1 and type 2 diabetes—gets all the attention with its rising global prevalence and connection to lifestyle and autoimmunity. Meanwhile, its lesser-known ...

Please provide your email address to receive an email when new articles are posted on . A group of representatives from national and international endocrine, nephrology and pediatric societies has ...

Desmoda oral solution is now FDA-approved for central diabetes insipidus, allowing clinicians to tailor dosing to individual water balance patterns.

FDA authorized desmopressin acetate oral solution (Desmoda) for CDI/AVP-D across all ages, representing the first FDA-approved oral liquid desmopressin formulation in the United States.